Role of endothelium in thrombosis and hemostasis

Annual Review of Medicine

Volumn 47, Issue , 1996, Pages 315-331

  Wu, K K ^a   Thiagarajan, P ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Endothelial cells; Gene transfer; Hemostasis; Inflammation; Nitric oxide; Prostacyclin; Thrombomodulin; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; HEPARIN; NITRIC OXIDE; PROCOAGULANT; PROSTACYCLIN; PROTEIN C; THROMBIN; THROMBOCYTE FACTOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BINDING SITE; BIOSYNTHESIS; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; FIBRINOLYSIS; GENE TRANSFER; HEMOSTASIS; HUMAN; MITOGENESIS; MONOCYTE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FIBRINOLYSIS; FIBROMUSCULAR DYSPLASIA; HEMOSTASIS; HUMANS; NITRIC OXIDE; PLATELET ACTIVATION; RISK FACTORS; THROMBOSIS; VASODILATION;

EID: 0030005626     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.47.1.315     Document Type: Review

References (50)

1. Belloni P, Nicolson GL. 1988. Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cell cultures. J. Cell Physiol. 136:398-410
2. Wu KK. 1992. Endothelial cells in hemostasis, thrombosis and inflammation. Hosp. Practice April 15:145-66
3. 2 and prostacyclin. Pharmacol. Rev. 30:293-331
4. Wu KK, Kulmacz RJ, Wang L-H, et al. 1992. Molecular biology of prostacyclin biosynthesis. In Prostacyclin: New Prospectives for Basic Research and Novel Therapeutic Indications, ed. GM Rubanyi, J Vane, pp 11-23. New York: Elsevier Sci.
5. Wu KK. 1995. Inducible cyclooxygenase and nitric oxide synthase. Adv. Pharmacol. 33:179-207
6. 2 in response to histamine, bradykinin and ATP. J. Clin. Invest. 76:271-80
7. Kent RS, Diedrich SL, Whorton R. 1983. Regulation of vascular prostaglandin synthesis by metabolites of arachidonate in perfused rabbit aorta. J. Clin. Invest. 72: 455-65
8. Xu X-M, Ohashi K, Sanduja SK, et al. 1993. Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA. J. Clin. Invest. 91:1843-49
9. Sanduja SK, Tsai A-L, Matijevic-Aleksic N, et al. 1994. Kinetics of prostacyclin synthesis in PGHS-1 over-expressed endothelial cells. Am. J. Physiol. 267: C1459-66
10. Hla T, Nielson K. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89:7384-88
11. DeWitt DL, Smith WL. 1983. Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. J. Biol. Chem. 258:3285-93
12. Hara S, Miyata A, Yokoyama C, et al. 1994. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J. Biol. Chem. 269:19897-903
13. Pereira B, Wu KK, Wang L-H. 1994. Molecular cloning and characterization of bovine prostacyclin synthase. Biochem. Biophys. Res. Comm. 203:59-66
14. Wu KK, Papp AC. 1990. Interaction between platelets and lymphocytes in biosynthesis of prostacyclin. Methods Enzymol. 187:578-84
15. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-42
16. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:687-92
17. Radomski MW, Palmer PMJ, Moncada S. 1987. The anti-aggregating properties of vascular endothelium interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:639-46
18. Marsden PA, Hing HHQ, Scherer SW, et al. 1993. Structure and chromosomal localization of human endothelial nitric oxide synthase. J. Biol. Chem. 268:17478-88
19. Zembowicz A, Tang J-L, Wu KK. 1995. Transcriptional induction of endothelial nitric oxide synthase by lysophosphatidylcholine. J. Biol. Chem. 270:17006-10
20. FitzGerald GA, Pedersen AK, Patrono C. 1984. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 67:1174-77
21. Marcus AJ, Safier LB, Haffar KA, et al. 1990. Inhibition of platelet function by an aspirin-insensitive endothelial cell AD-Pase. J. Clin. Invest. 88:1690-96
22. Esmon CT. 1993. Molecular events that control the protein C anticoagulant pathway. Thromb. Haemost. 70:29-35
23. Thompson EA, Salem HH. 1986. Inhibition of human thrombomodulin of factor Xa mediated cleavage of prothrombin. J. Clin. Invest. 78:13-17
24. Preissner KT, Delvos U, Muller-Bergaus G. 1987. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for heparin-independent mechanism. Biochemistry 26:2521-28
25. Dahlback B. 1984. Interaction between vitamin K-dependent protein S and complement protein, C4b-binding protein. Semin. Thromb. Haemost. 10:139-45
26. Fukudome K, Esmon CT. 1995. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). J.Biol. Chem. 270:5571-76
27. Rosenberg RD, Bauer KA. 1994. The heparin-antithrombin system: a natural anticoagulant mechanism. In Hemostasis and Thrombosis, ed. RW Coleman, J Hirsch, VJ Marder, EW Salmon, pp. 837-60. Philadelphia, PA: Lippincott
28. Tollefsen DM, Marrone, MM, McGuire EA, et al. 1989. Heparin cofactor II activation by dermatan sulfate. Ann. NY Acad. Sci. 556:116-22
29. Rappaport SI, Rao LV. 1991. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler. Thromb. 12: 1111-21
30. Girard TJ, Broze GJ Jr. 1993. Tissue factor pathway inhibitor. Methods Enzymol. 222: 195-209
31. Haskel EF, Torr, SR, Day KC, et al. 1991. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated with coagulation inhibitor. Circulation 84:821-27
32. Handin RI, Wagner DD. 1989. Molecular and cellular biology of von Willebrand factor. Prog. Haemost. Thrombo. 9:233-45
33. Ruggeri ZM. 1994. Glycoprotein Ib and von Willebrand factor in the process of thrombus formation. Ann. NY Acad. Sci. 714:200-10
34. Moake JL, Turner NA, Stathopoulos NA, et al. 1986. Involvement of large plasma vWF multimers in shear-stress induced platelet aggregation. J. Clin. Invest. 78: 1456-61
35. Lopez JA. 1994. The platelet glycoprotein Ib-IX complex. Blood Coagul. Fibrinolysis 5:97-119
36. Zembowicz A, Jones SL, Wu KK. 1995. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J. Clin. Invest. 96:1688-92
37. Stern DM, Kaiser E, Nawroth PP. 1988. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 18: 202-14
38. Ryan J, Brett J, Tijburg P, et al. 1994. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80:966-74
39. Ogawa S, Shreeniwas R, Butura C, et al. 1990. Modulation of endothelial function by hypoxia: perturbation of barrier and anticoagulant function, and induction of a novel factor X activator. Adv. Exp. Med. Biol. 281:303-12
40. Key NS, Vercellotti GM, Winkelmann JC, et al. 1991. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc. Natl. Acad. Sci. USA 87:7095-99
41. Wilcox JN, Smith KM, Schwartz SM, et al. 1989. Localization of tissue factor in normal vessel wall in atherosclerotic plague. Proc. Natl. Acad. Sci. USA 86:2839-43
42. Fleck RA, Rao LV, Rapaport SI, et al. 1990. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb. Res. 59:421-37
43. Drake TA, Cheng J, Chang A, et al. 1993. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am. J. Physiol. 143:1458-70
44. Weiss HJ, Hoffmann T, Turitto VT, et al. 1994. Further studies on the presence of functional tissue factor activity on the subendothelium of normal human and rabbit arteries. Thromb. Res. 73:313-26
45. Bevilacqua MP. 1993. Endothelial-leukocyhte adhesion molecules. Annu. Rev. Immunol. 11:767-804
46. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistop paradigm. Cell 76: 301-14
47. Wu KK, Zoldhelyi P, Willerson JT, et al. 1994. Restoration of prostacyclin synthesis by transfer of PGHS cDNA. Adv. Prostagl. Thrombox. Leukotri. Res. 23:377-80
48. Von der Leyen HE, Gibbons GH, Morishita R, et al. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 92:1137-41
49. Simon RH, Engelhardt JF, Yang Y, et al. 1993. Adenovirus-mediated gene transfer of the CFTR gene to lungs of nonhuman primates: toxicity study. Hum. Gene Ther. 4:771-80
50. Feldman LJ, Steg PG, Zheng LP, et al. 1995. Low efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest. 95:2662-71